Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IASOS: Orismilast in Moderate-to-Severe Plaque Psoriasis
NCT05190419Phase 2Completed
- Sponsor
- UNION therapeutics
- Start
- Dec 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of orismilast in plaque psoriasis, sponsored by UNION therapeutics. Started Dec 2021; status: completed.
02
Drugs
orismilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05190419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05190419.